{"id":2179,"date":"2018-01-08T17:23:49","date_gmt":"2018-01-08T17:23:49","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=33929"},"modified":"2018-01-08T17:23:49","modified_gmt":"2018-01-08T17:23:49","slug":"medical-marijuana-inc-subsidiaries-hempmeds-mexico-hempmeds-brazil-kannaway-announce-2017-largest-revenue-year-company-history","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2018\/01\/08\/medical-marijuana-inc-subsidiaries-hempmeds-mexico-hempmeds-brazil-kannaway-announce-2017-largest-revenue-year-company-history\/","title":{"rendered":"Medical Marijuana, Inc. and Subsidiaries HempMeds\u00ae Mexico, HempMeds\u00ae Brazil and Kannaway\u00ae Announce 2017 as the Largest Revenue Year in Company History"},"content":{"rendered":"
SAN DIEGO, Jan.\u00a08, 2018 —\u00a0Medical Marijuana, Inc.\u00a0(OTC:\u00a0MJNA), the first-ever publicly traded cannabis company in\u00a0the United States, today announced that the Company and its subsidiaries HempMeds\u00ae Mexico, HempMeds\u00ae Brazil and Kannaway\u00ae generated the largest-ever (unaudited) revenue year in its history in 2017, as well as reached major milestones in its business operations.<\/p>\n
In 2017, Medical Marijuana, Inc. had a number of significant accomplishments, including:<\/p>\n
Medical Marijuana, Inc. subsidiary\u00a0Kannaway\u00ae<\/a>\u00a0was the first direct sales company to offer phyto-cannabinoid botanical products to consumers. A family-oriented company, Kannaway\u00ae encourages its brand ambassadors to create their own successful distribution businesses that will positively benefit the wellbeing of the people around them.<\/p>\n In 2017, Kannaway\u00ae had a number of significant accomplishments including:<\/p>\n HempMeds\u00ae Mexico<\/a>\u00a0is Medical Marijuana, Inc.’s distribution branch in the country, focusing on providing non-psychoactive\u00a0cannabidiol (CBD) products to the people of Mexico. HempMeds\u00ae Mexico was the first company to have a medical cannabis product approved for import into Mexico.<\/p>\n In 2017, HempMeds\u00ae Mexico had a number of significant accomplishments including:<\/p>\n Another Latin American subsidiary of Medical Marijuana, Inc.,\u00a0HempMeds\u00ae Brazil<\/a>, is the distribution partner in this country. Medical Marijuana, Inc.’s flagship product, Real Scientific Hemp Oil\u2122(RSHO\u2122) was the first cannabis product to be approved for import by Brazil’s federal government and used as a prescription for approved medical indications within Brazil.<\/p>\n In 2017, HempMeds\u00ae Brazil had a number of significant accomplishments including:<\/p>\n “We are excited to have surpassed our growth and revenue goals for this year,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “By breaking our annual sales record (pre-audit numbers) and investing into our future expansion efforts, we can provide our shareholders with an optimistic forecast for our future success.\u00a0 We expect to again set company-wide sales records in 2018 and are excited about the trends within the industry, including the growing acceptance of our products to a national and international audience.”<\/p>\n “The Company and its subsidiaries have worked incredibly hard this year to further global access to CBD,” said Medical Marijuana, Inc. Chief Operating Officer Blake Schroeder. “Because of this year’s international expansion, our products are now available domestically, throughout Europe, and in a number of Latin American countries.\u00a0 We look forward to seeing that number continue to rise in 2018.”<\/p>\n About Medical Marijuana, Inc.<\/strong><\/p>\n We are a company of firsts\u00ae.<\/a>\u00a0Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit\u00a0www.medicalmarijuanainc.com<\/a>.<\/p>\n To see Medical Marijuana, Inc.’s corporate video,\u00a0click here<\/a>.<\/p>\n Shareholders are also encouraged to visit the\u00a0Medical Marijuana, Inc. Shop<\/a>\u00a0for discounted products.<\/p>\n FORWARD-LOOKING DISCLAIMER AND DISCLOSURES<\/strong><\/p>\n This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.<\/p>\n The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease.\u00a0 The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.<\/p>\n CONTACT:<\/strong><\/p>\n Public Relations Contact:<\/strong><\/p>\n Andrew Hard<\/p>\n Chief Executive Officer<\/p>\n CMW Media<\/p>\n P: 888-829- 0070<\/p>\n\n
\n
\n